Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Express Scripts
Harvard Business School
McKesson
McKinsey

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FENTANYL CITRATE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Fentanyl Citrate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00105287 Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients Completed Cephalon Phase 3 2005-01-01 The purpose of this study is to evaluate the safety and tolerability of OraVescent fentanyl when used long-term to relieve breakthrough pain in opioid tolerant cancer patients.
NCT00105937 OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients Completed Cephalon Phase 3 2004-04-01 The purpose of this study is to evaluate the long-term safety and efficacy of OraVescent fentanyl to treat breakthrough pain episodes in cancer patients who are already opioid tolerant.
NCT00125801 The Pain Pen for Breakthrough Cancer Pain Terminated Erasmus Medical Center Phase 3 2005-08-01 The purpose of this study is to see whether injection of hydromorphone through a subcutaneous injection device is more effective in treating breakthrough cancer pain than oral morphine.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Fentanyl Citrate

Condition Name

Condition Name for Fentanyl Citrate
Intervention Trials
Pain 16
Cancer 8
Breakthrough Pain 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Fentanyl Citrate
Intervention Trials
Breakthrough Pain 16
Pain, Postoperative 6
Dyspnea 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Fentanyl Citrate

Trials by Country

Trials by Country for Fentanyl Citrate
Location Trials
United States 188
India 6
Egypt 4
Canada 4
Puerto Rico 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Fentanyl Citrate
Location Trials
New York 11
Florida 10
California 10
Texas 10
North Carolina 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Fentanyl Citrate

Clinical Trial Phase

Clinical Trial Phase for Fentanyl Citrate
Clinical Trial Phase Trials
Phase 4 13
Phase 3 22
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Fentanyl Citrate
Clinical Trial Phase Trials
Completed 38
Not yet recruiting 11
Recruiting 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Fentanyl Citrate

Sponsor Name

Sponsor Name for Fentanyl Citrate
Sponsor Trials
Cephalon 11
Eisai Inc. 7
PPD 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Fentanyl Citrate
Sponsor Trials
Industry 48
Other 47
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Dow
Johnson and Johnson
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.